News & Announcements

Category: Uncategorized

TransMed7, LLC Announces First Clinical Use of VacuPac®, a New Self-Contained, Vacuum-Assist Attachment for all of its Vacuum-Assisted, Single Insertion – Multiple Collection (SIMC®) Platforms of Biopsy Devices

Portola Valley, CA, March 21, 2023 – TransMed7, LLC announced today the first clinical use of VacuPac®, a new self-contained external vacuum-assist

TransMed7, LLC Announces First Clinical Cases of Concorde Soft Tissue Biopsy Devices for Commercial Launch

Portola Valley, CA, February 6, 2023 – TransMed7, LLC announced today that the “First in Human” series of clinical cases using commercial

TransMed7, LLC Announces First Clinical Use of Heron Soft Tissue Biopsy Devices for Commercial Launch

Portola Valley, CA, August 16, 2022 – TransMed7, LLC announced today that the “First in Human” clinical case of the commercial production

TransMed7, LLC Announces First Clinical Use of SpeedBird™ Breast Biopsy Devices for Commercial Launch

Portola Valley, CA, August 8, 2022 – TransMed7, LLC announced today that the first clinical cases of the final commercial production version

TransMed7, LLC Announces First Results from Clinical Use of its Vacuum-Assisted, Single Insertion – Multiple Collection (SIMC™) Platform of Breast Biopsy Devices

PHOENIX, AZ, September 22, 2020 – TransMed7, LLC announced today that the first of the vacuum-assisted, Single Insertion – Multiple Collection (SIMC™)

TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its Concorde US
(Ultrasound) and Concorde ST (Stereotactic) Soft Tissue Biopsy Device Platform

Portola Valley, CA –TransMed7, LLC announced today that the United States Food and Drug Administration (FDA) has cleared its 510(k) application for the company to market TransMed7’s new Concorde USTM and Concorde STTM soft tissue biopsy devices.